Form D · Biotechnology
Ikonopedia, Inc.
Dallas, TX · CIK 0001544904
Offering snapshot reported Mar 12, 2013 · SEC filing
- Reported sold
- $75K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 7, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2013 | Initial | $75,000 | No comparison | 2 | SEC filing |
| Jul 30, 2012 | Amendment | $1,000,000 | No comparison | 19 | SEC filing |
| May 1, 2012 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Mar 28, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-193144
Source: Form D, filed Mar 12, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Woodrow Gandy | Director |
| Ronald A. Hellstern | Executive |
| A. Thomas Stavros | Promoter |
| A Thomas Stavros | Director, Promoter |
| Scott Stoll | Executive |
| Lazlo Tabar | Promoter |
| Laszlo Tabar | Promoter |
| Michael J Vendrell | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12001 N. Central Expressway, Suite 1000
Dallas, TX, 75243
Dallas, TX, 75243